Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleArticle
Open Access

Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer

TAKAAKI MASUDA, HIROAKI UEO, YUTA OKUMURA, YUICHIRO KAI, YUKI ANDO, KEN MASUGUCHI, MIWA KITAGAWA, AKIHIRO KITAGAWA, NAOKI HAYASHI, YUSUKE TSURUDA, YUICHI HISAMATSU, SHUJI SUEHIRO, HIROFUMI OHMURA, KENJI FUJIYOSHI, FUMIAKI TANAKA and KOSHI MIMORI
Cancer Genomics & Proteomics March 2023, 20 (2) 182-194; DOI: https://doi.org/10.21873/cgp.20373
TAKAAKI MASUDA
1Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROAKI UEO
2Ueo Breast Cancer Hospital, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUTA OKUMURA
3Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUICHIRO KAI
2Ueo Breast Cancer Hospital, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKI ANDO
1Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEN MASUGUCHI
4Department of Pharmacy, Kyushu University Beppu Hospital, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIWA KITAGAWA
1Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan;
5Department of Breast Surgery, Medical Corporation Kyoujinkai Komatsu Hospital, Osaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIHIRO KITAGAWA
1Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan;
6Department of Surgery, Sakai City Medical Center, Osaka, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NAOKI HAYASHI
1Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUSUKE TSURUDA
1Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUICHI HISAMATSU
1Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUJI SUEHIRO
7Department of Breast Surgery, Tsurumi Hospital, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROFUMI OHMURA
3Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENJI FUJIYOSHI
8Fujiyoshi Breast Clinic, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FUMIAKI TANAKA
1Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan;
9Tanaka Breast, Surgery, Internal Medicine Clinic, Oita, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOSHI MIMORI
1Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mimori.koshi.791{at}m.kyushu-u.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 20 no. 2 182-194
DOI 
https://doi.org/10.21873/cgp.20373
PMID 
36870689

Published By 
International Institute of Anticancer Research
Print ISSN 
1109-6535
Online ISSN 
1790-6245
History 
  • Received November 24, 2022
  • Revision received December 15, 2022
  • Accepted December 19, 2022
  • Published online March 4, 2023.

Copyright & License 
Copyright © 2023 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

  1. TAKAAKI MASUDA1,
  2. HIROAKI UEO2,
  3. YUTA OKUMURA3,
  4. YUICHIRO KAI2,
  5. YUKI ANDO1,
  6. KEN MASUGUCHI4,
  7. MIWA KITAGAWA1,5,
  8. AKIHIRO KITAGAWA1,6,
  9. NAOKI HAYASHI1,
  10. YUSUKE TSURUDA1,
  11. YUICHI HISAMATSU1,
  12. SHUJI SUEHIRO7,
  13. HIROFUMI OHMURA3,
  14. KENJI FUJIYOSHI8,
  15. FUMIAKI TANAKA1,9 and
  16. KOSHI MIMORI1⇑
  1. 1Department of Surgery, Kyushu University Beppu Hospital, Oita, Japan;
  2. 2Ueo Breast Cancer Hospital, Oita, Japan;
  3. 3Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan;
  4. 4Department of Pharmacy, Kyushu University Beppu Hospital, Oita, Japan;
  5. 5Department of Breast Surgery, Medical Corporation Kyoujinkai Komatsu Hospital, Osaka, Japan;
  6. 6Department of Surgery, Sakai City Medical Center, Osaka, Japan;
  7. 7Department of Breast Surgery, Tsurumi Hospital, Oita, Japan;
  8. 8Fujiyoshi Breast Clinic, Oita, Japan;
  9. 9Tanaka Breast, Surgery, Internal Medicine Clinic, Oita, Japan
  1. Correspondence to: Koshi Mimori, MD, Ph.D., Department of Surgery, Kyushu University Beppu Hospital, 4546 Tsurumibaru, Beppu 874-0838, Japan. Tel: +81 977271650, Fax: +81 977271651, e-mail: mimori.koshi.791{at}m.kyushu-u.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 4 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Cancer Genomics - Proteomics: 20 (2)
Cancer Genomics & Proteomics
Vol. 20, Issue 2
March-April 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer
TAKAAKI MASUDA, HIROAKI UEO, YUTA OKUMURA, YUICHIRO KAI, YUKI ANDO, KEN MASUGUCHI, MIWA KITAGAWA, AKIHIRO KITAGAWA, NAOKI HAYASHI, YUSUKE TSURUDA, YUICHI HISAMATSU, SHUJI SUEHIRO, HIROFUMI OHMURA, KENJI FUJIYOSHI, FUMIAKI TANAKA, KOSHI MIMORI
Cancer Genomics & Proteomics Mar 2023, 20 (2) 182-194; DOI: 10.21873/cgp.20373

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer
TAKAAKI MASUDA, HIROAKI UEO, YUTA OKUMURA, YUICHIRO KAI, YUKI ANDO, KEN MASUGUCHI, MIWA KITAGAWA, AKIHIRO KITAGAWA, NAOKI HAYASHI, YUSUKE TSURUDA, YUICHI HISAMATSU, SHUJI SUEHIRO, HIROFUMI OHMURA, KENJI FUJIYOSHI, FUMIAKI TANAKA, KOSHI MIMORI
Cancer Genomics & Proteomics Mar 2023, 20 (2) 182-194; DOI: 10.21873/cgp.20373
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Recurrent 8q11-13 Aberrations Leading to PLAG1 Rearrangements, Including Novel Chimeras HNRNPA2B1::PLAG1 and SDCBP::PLAG1, in Lipomatous Tumors
  • Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis
  • Oncogenes and Methionine Addiction of Cancer: Role of c-MYC
Show more Article

Keywords

  • Breast cancer
  • NLR
  • ALC
  • immunity
  • chemotherapy
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire